Interleukin-1 (IL-1) inhibitor/IL-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-1 (IL-1) inhibitor/IL-1, covering 2023-05-15 to 2023-05-15. Get the full timeline:
Most recent: Clinical Trial Update: BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer [Phase 1, Phase 2]